Background. Acute kidney injury (AKI) is a common complication in patients admitted to the intensive care unit (ICU). Among other variables, serum urea concentrations are recommended for timing of initiation of renal replacement therapy (RRT). The aim of this study was to evaluate whether serum urea concentration or different serum urea concentration cutoffs as recommended in the literature were associated with in-hospital mortality at time of initiation of RRT for AKI. Methods. This is a retrospective single-centre study during a 3-year period , in a 44-bed tertiary care centre ICU of adult AKI patients who were treated with RRT. Results. Three hundred and two patients were included: 68.9% male, median age 65 years and an APACHE II score of 21. The overall in-hospital mortality was 57.9%. Nonsurvivors were older (67 versus 64 years, P ¼ 0.016) and had a higher APACHE II score (22 versus 20, P < 0.001). At time of initiation of RRT, they were more severely ill and had a lower serum urea concentration compared to survivors (130 versus141 mg/dL, P ¼ 0.038). Serum urea concentration, as well as the different historical serum urea concentration cut-offs had low area under the curves for the receiver operating characteristic curve for prediction of mortality. In multivariate analysis, age, and at time of initiation of RRT, potassium, SOFA score with exclusion of points for AKI and RIFLE class were associated with mortality, but serum urea concentration and the different cut-offs were not. Conclusions. This retrospective study suggests that serum urea concentration and serum urea concentration cut-offs at time of initiation of RRT have no predictive value for in-hospital mortality in ICU patients with AKI.
Introduction
Acute Kidney Injury (AKI) treated with renal replacement therapy (RRT) occurs in~5% of ICU patients and has an incidence of approximately 200-300 patients per million inhabitants, comparable to the incidence of acute lung injury and acute respiratory distress syndrome [1] [2] [3] [4] [5] [6] [7] . It is associated with worse outcomes, such as increased length of stay, end-stage renal disease, cost and short-and long-term mortality [2, 3] . Despite over five decades of experience with RRT for AKI, there is still no firm evidence on the criteria for initiation of RRT. According to an expert working group of the Acute Kidney Injury Network (AKIN), who summarized the available evidence, absolute indications for initiation of RRT include a serum urea concentration >224 mg/ dL (BUN > 100 mg/dL), hyperkalaemia (>6 mmol/L and ECG abnormalities), hypermagnesaemia (>8 mEq/L), severe acidosis (pH <7.15), lactic acidosis related to methformin use and anuria with diuretic resistant volume overload. In patients with AKI who do not fulfill absolute indications, a serum urea concentration >170 mg/dL (BUN > 76 mg/dL) is considered a relative indication for initiation of RRT [8] . Serum urea concentrations have been used for timing of initiation of RRT since the early days of treatment of AKI patients. Since the 1960s, there is a trend to initiate RRT at lower serum urea concentrations (Table 1) . One recent and several older studies found that a lower serum urea concentration at initiation of RRT was associated with better outcome [9] [10] [11] [12] [13] [14] [15] . Only three prospective intervention studies have evaluated this issue [16] [17] [18] . None of these could demonstrate that initiation at lower serum urea concentration had an impact on outcome.
In view of the contradictions reported in the literature, we aimed to assess the relationship between serum urea concentration at time of initiation of RRT and in-hospital mortality.
Materials and methods
This is a retrospective analysis of prospectively collected data to study the effect of serum urea concentration at initiation of RRT on in-hospital mortality.
Study population
We analysed all ICU patients, age !15 year who had AKI and were treated with RRT during the period 2004-07 at the Ghent University Hospital ICU and who were included in the electronic ICU patient database management system. The ICU includes a 22 bed Surgical, 14 bed Medical, 6 bed Burn and 8 bed Cardiac Surgery ICU. Patients admitted to the Burn ICU were excluded from analysis because serum urea concentration in this cohort may be disproportionally increased compared to other types of ICU patients. Other exclusion criteria were extracorporeal blood purification techniques for other reasons than AKI, patients on chronic RRT, RRT initiated before admission to the ICU and RRT immediately post-kidney transplant. Treatment episodes with peritoneal dialysis, a modality incidentally used in our ICU, were also not considered. Indications for RRT, as well as the modality chosen [i.e. intermittent (duration 2-4 h per treatment session) or continuous haemodialysis (IHD/CHD), continuous veno-venous haemofiltration (CVVH) or slow extended daily dialysis (SLEDD) (duration 6-12 h per treatment session)], were determined in consensus between the attending intensivists and nephrologists [19] .
Data collection
Demographic data were retrieved from the electronic hospital database, laboratory data from the laboratory database and patient data from the electronic ICU patient database management system. Data were prospectively recorded at time of ICU admission and at time of initiation of RRT. For every parameter, the most abnormal value per day was registered. Serum concentrations of urea, creatinine, sodium and potassium were collected on admission at ICU and at the start of RRT. Serum creatinine was collected at time of hospital admission. SAPS II (Simplified Acute Physiology Score) and APACHE II (Acute Physiologic Assessment and Chronic Health evaluation) scores were calculated on data collected during the first day of admission [20, 21] . At time of initiation of RRT, we calculated the SOFA score (Sequential Organ Failure Assessment) [22] and a SOFA score with omission of points for kidney insufficiency (SO-FA non-renal ) [23] . Severity of AKI was also assessed at time of initiation of RRT by the RIFLE classification subdividing AKI into three categories of severity (Risk, Injury and Failure) and two categories of clinical outcome (Loss and End-stage renal disease). RIFLE severity class was assessed on serum creatinine criteria only. For patients without chronic kidney insufficiency as reported in the medical history, we calculated a serum creatinine level using the MDRD equation as recommended by the Acute Dialysis Quality Initiative, by using the MDRD equation for serum creatinine assuming a glomerular filtration rate of 75 mL/min/1.73 m 2 [24] . Baseline serum creatinine was the lowest of either creatinine at time of hospital admission or the MDRD-based estimation of baseline creatinine [23] .
Statistical analysis
Data are expressed as number (percentage) or median (interquartile range). Bivariate analysis was performed with the Mann-Whitney U-test, Fisher exact test and v 2 test as appropriate. In addition, we calculated odds ratios and sensitivity and specificity for serum urea concentration cut-offs for timing of initiation of RRT mentioned in Table 1 . The median serum urea concentration of the whole cohort was taken as a cut-off concentration for the bivariate analysis on patients with low and high serum urea concentration. The relationship between serum urea concentration at time of initiation of RRT and in-hospital mortality was explored by construction of receiver operating characteristic curves (ROCs) and calculation of the area under the ROC curve (AUC). ROC graphs are constructed by plotting sensitivity and specificity of serum urea concentration at time of initiation of RRT (as continuous variable) and serum urea cut-offs that are described in the literature (as categorical variables) for in-hospital mortality. An AUC of 0.5 indicates that the test has low sensitivity and specificity and performs as good as tossing a coin, and an AUC of one indicates an ideal test with 100% sensitivity and specificity for the outcome variable. Multivariate logistic regression analysis was used to examine, which variables were associated with mortality. Variables selected for inclusion in the regression model were those with a P-value of 0.25 in bivariate analysis when comparing survivors and non-survivors. We analysed for colinearity by assessing correlation between covariates, also interaction was explored. Goodness of fit was assessed according to the method described by Hosmer and Lemeshow. Statistical significance was accepted when the P-value was <0.05. A propensity model was included in the final model. A power analysis to define sample size was performed.
A power calculation showed that two groups of 154 patients would be needed to give 80% power to detect a difference in mortality based on a 5% level of significance. These analyses were performed with use of the statistical software packages SPSS (SPSS for Windows, version 15.0.0) and MedCalc for Windows, version 9.6.0.0 (MedCalc Software, Mariakerke, Belgium). There was only a serum urea concentration cut-off for the high urea group. The concentrations in the table for the two low serum urea concentration groups are the median serum urea concentrations at time of initiation of RRT. The P-value was calculated on the pooled results of the two groups with low serum urea concentration (low volume and high volume haemofiltration) compared to the group with late initiation.
The study was approved by the Ethics Committee of the Ghent University Hospital and conducted in accordance with the Declaration of Helsinki. Informed consent was waived for this study.
Results

Baseline characteristics
From a total of 482 ICU patients who were treated with RRT, 302 patients were included in the study. A total of 180 patients who underwent RRT could not be included because of the gradual introduction of the patient database management system over the three different ICUs during the study period. Median age of the patients was 65 years (55, 73), 208 were male (68.9%). At time of ICU admission, the APACHE II score was 21 (16, 26) , the SAPS II score was 45 (34, 62) . One hundred twenty-nine patients (42.7%) were treated in the Surgical ICU, 100 patients (33.1%) in the Medical ICU and 73 patients (24.2%) in the Cardiac Surgery ICU. The initial mode of RRT was IHD in 162 patients (53.6%), CHD in 71 (23.5%), CVVH in 44 (14.6%) and SLEDD in 25 (8.3%). At time of initiation of RRT, the SOFA score and the SOFA non-renal score were 10 (7, 12), and 6 (4, 8), respectively. RIFLE criteria were not met in 10 patients (3.3%), 21 patients were RIFLE-Risk (7%), 62 patients RIFLE-Injury (20.5%) and 209 patients were RIFLE -Failure (69.2%). Diuretics were administered in 135 patients (44.7%), 171 patients (56.6%) were mechanically ventilated and 209 (69.2%) were treated with vasoactive drugs. The overall in-hospital mortality of this study cohort was 57.9%. Serum urea concentration at time of initiation of RRT as a predictor for outcome
Patients with a low serum urea concentration were more severely ill on admission. Differentiation in low versus high serum urea concentration was based on the median serum urea concentration at initiation of RRT (Table 2) . Patients were more acidotic, had higher serum potassium and a lower serum creatinine. RIFLE class was lower in patients with lower serum urea concentration. A greater proportion was haemodynamically unstable, as illustrated by the greater proportion of treatments with a continuous RRT modality and the clear trend for more patients on vasoactive drugs. There was a trend for worse outcome in patients with low serum urea concentration.
Bivariate analysis. We explored the different serum urea cut-offs as reported in the literature (Table 1) in our cohort. At the present time, there is a trend to initiate RRT earlier in the course of AKI. Therefore, we also analysed two other serum urea concentration cut-offs (serum urea concentration 70 and 100 mg/dL). None of the serum urea concentration cut-offs, except serum urea >100 [15] and >170 mg/dL [14] and were associated with mortality in bivariate analysis (Table 3) . However, in our study cohort, patients with higher serum urea had lower instead of higher inhospital mortality. Serum urea concentration at time of initiation of RRT, measured as a continuous variable, as well as the different serum urea concentration cut-offs that are mentioned in the literature (Table 1) had poor sensitivity and specificity and therefore low AUC for the ROC curves for prediction of in-hospital mortality (Figures 1  and 2 ).
Multivariate analyses. We evaluated if serum urea concentration at time of initiation of RRT was associated with inhospital mortality. We analysed different multivariate logistic regression models (Table 4) . In Model 1, covariates used for adjustment were age, APACHE II score and type of ICU (medical ICU, surgical ICU and cardiac surgery ICU). Covariates used for adjustment in Model 2 were variables in Model 1 and variables at time of initiation of RRT: modality of RRT, SOFA non-renal , RIFLE class, lowest pH, maximum potassium and phosphorus. Finally, we included a propensity score in the multivariate model to correct for possible bias leading to some patients being put on RRT earlier. In our propensity model, we included the following data: sex, APACHE II, RIFLE, ICU type, urine output (24 h) and creatinine on admission. Including this propensity score in our model, we still found no association between serum urea and in-hospital mortality (Table 5 and Figure 3 ). We performed a sensitivity analysis and analysed the same model in subgroups of patients with low and high serum urea concentration. This demonstrated in the two subgroups that serum urea concentration and mortality were not associated (data not shown).
Discussion
Timing of initiation of RRT for AKI and outcome have been traditionally linked to serum urea concentration cutoffs. This could not be confirmed in our dataset of ICU patients with AKI who were treated with RRT. Serum urea concentration at time of initiation of RRT as a continuous variable was also not associated with in-hospital mortality. Despite the limitations of serum urea concentration as a marker for kidney function [25] , it is traditionally used as a surrogate marker for severity and duration of the AKI episode. Several studies dating back from the 1960s until 2001 suggested that certain serum urea concentration cut-offs were predictive for in-hospital mortality. In the 1960s, Teschan et al. [26] introduced the concept of prophylactic dialysis based on serum urea concentration, i.e. initiation of RRT before occurrence of uraemic symptoms. Several retrospective studies published from then on, suggested that initiation of RRT at lower serum urea concentrations or earlier in the course of AKI indeed were associated with improved outcome (Table 1) [9] [10] [11] [12] [13] [14] . Although the first prospective randomized study on this topic did not reach statistical significance, a clear trend supported this concept [16] . Two other prospective studies could not demonstrate that early initiation of RRT at lower serum urea concentrations was associated with better outcomes [17, 18] .
Despite this, the current paradigm is that timing of initiation of RRT for AKI may be based on a series of clinical and biochemical variables, including certain serum urea concentrations. Also, a recent meta-analysis concluded that early initiation of RRT may be associated with improved survival. Thirteen of the 23 included studies used serum urea as a criterion for initiation of RRT [27] . In 2008, the AKIN consensus group proposed, based on the existing literature, serum urea > 224 mg/dL as an absolute and serum urea > 170 mg/dL as a relative indication for initiation of RRT [8] .
Our findings shed new light on this discussion. Serum urea was not a good predictor for worse outcome in ICU patients with AKI. Several elements may be involved in these findings.
First, the serum urea concentration paradigm for timing of initiation of RRT is based on limited evidence and mostly old studies. The patient cohorts described in these hallmark studies are not comparable to the AKI patients we are nowadays treating. The prospective studies on this topic were performed 10-38 years ago, are underpowered, and include very specific cohorts of patients that do not necessarily have external validity.
Second, serum urea concentration is determined by numerous other variables that have no relation to kidney function, such as catabolism, administration of corticosteroids, gastrointestinal bleeds, etc. Also, increased serum urea concentrations very likely have limited biological effects as observed in current clinical conditions [28, 29] .
Third, patients with higher serum urea concentration at time of initiation of RRT in our cohort were less severely ill compared to the low serum urea concentration cohort. In most patients, RRT will be initiated immediately and early in the course of AKI for indications such as severe acid-base disturbances, severe hyperkalaemia or fluid overload. In this setting, serum urea concentration at time of initiation of RRT is relatively low, although this group of patients is severely ill and has worse prognosis. The most plausible explanation for the absence of a relation between serum urea concentration and outcome is the fact that RRT is initiated early in the group of more severely ill patients, i.e. before serum urea concentration has had the time to rise.
In contrast to our findings concerning the impact of serum urea concentrations on outcome, multivariate analysis demonstrated that factors such as age and severity of nonrenal illness did have an important impact on mortality.
Finally, our data revealed an inverse association between increasing RIFLE class and outcome. This may seem against intuition but is in line with current literature. Increasing severity of maximum RIFLE class has been shown repeatedly to be associated with a stepwise increase in mortality and length of ICU stay [23, [30] [31] [32] . However, RIFLE class determined at time of RRT initiation was never associated with outcome [33, 34] . Serum creatinine at time of initiation of RRT has an inverse relationship with outcome, possibly explained by the fact that serum creatinine also serves as a surrogate marker for other comorbid diseases that may impact outcome. For instance, older patients with chronic disease or patients who were already hospitalized for a longer time have less muscle mass, leading to lower creatinine concentration for a given glomerular filtration rate [25, 35] . This is to the best of our knowledge the only study that exclusively focuses on the prognostic value of serum urea concentration for timing of initiating of RRT in general ICU patients, as recently recommended by AKIN. Subsequently, this study meticulously evaluates the numerous and widespread used serum urea concentration cut-offs recommended in the literature. The strengths of this study include the high quality of the electronically collected data, the fact that recent data were collected on a relative large and well-powered study population that was representative for a tertiary ICU in a developed country and that in-hospital mortality (and not ICU mortality) was assessed as outcome.
The study also includes several limitations. First, its retrospective design can only be hypothesis generating on the topic of timing of initiation of RRT. Multivariate analysis is a tool that may correct for the observational design of the study. But such an analysis is only as good as the type and quality of the covariates that are entered into the model. Therefore, we analysed different multivariate logistic regression models. We also included a propensity score to correct for bias. Our database consisted of data on baseline characteristics of the patients and data recorded at time of initiation of RRT. However, covariates that were not available such as volume balance may also have had an important impact on outcome [36] . Also, RIFLE class was assessed on creatinine criteria only as we did not have detailed urine output data necessary for classifying. The results on RIFLE could be different when urine output was used as a criterium. However, this limitation is present in the majority of studies on the epidemiology of AKI [31, 37] . Second, similar to the majority of the studies on this topic, all patients in our study received RRT. Including AKI patients without RTT could have led to different conclusions. For instance, patients with low severity of AKI, low serum urea and without severe multiple organ dysfunction syndrome may have recovered AKI without RRT. Also, AKI patients with high serum urea levels may have died without RRT. In addition, initiation of RRT was in part based on serum urea concentrations as we follow consensus recommendations. However, the sensitivity analysis in the low and high serum urea concentration group could not demonstrate a difference in outcomes, suggesting that this bias was only limited. Further, the broad range of serum urea concentrations, with a median concentration of 136 mg/dL permits the evaluation of all urea cut-offs mentioned in the literature. Third, because our patient database management system was introduced gradually over the three different ICUs during the study period, we could not study all patients who underwent RRT. However, as we could not demonstrate a difference in outcome or serum urea concentration between the different ICUs, it is unlikely that this has influenced the results profoundly. Finally, the data reflect the practice from a single centre and may therefore not be applicable to other settings where Fig. 3 . Adjusted risk for in-hospital death for the different serum urea concentration cut-off as mentioned in literature (indicated by the first author), applied to our study cohort. A multivariate logistic regression analysis with adjustment for the same covariates as in Table 4 . other practice protocols for treatment of ICU patients with AKI are used.
Our findings highlight the need for a well-set-up prospective randomized trial on the timing of initiation of RRT. The design of such a trial needs careful consideration. We propose that patients in such a study are stratified according to severity of illness, with different criteria for initiation of RRT in the different strata. Given the arguments discussed above, we do not feel that serum urea concentration should still be a criterion in this study. RIFLE or AKI criteria have been proposed as alternatives [8] and are probably more accurate in differentiating early and less severe from progressed and more severe AKI.
In conclusion, this study suggests that serum urea concentration cut-offs at time of initiation of RRT, as they have been used from the early days of acute RRT and as they are actually recommended, have no predictive value for inhospital mortality in severely ill ICU patients with AKI.
